A Patient-Held Smartcard With a Unique Identifier and an mHealth Platform to Improve the Availability of Prenatal Test Results in Rural Nigeria: Demonstration Study

Background Community-based strategies to test for HIV, hepatitis B virus (HBV), and sickle cell disease (SCD) have expanded opportunities to increase the proportion of pregnant women who are aware of their diagnosis. In order to use this information to implement evidence-based interventions, these results have to be available to skilled health providers at the point of delivery. Most electronic health platforms are dependent on the availability of reliable Internet connectivity and, thus, have limited use in many rural and resource-limited settings. Objective Here we describe our work on the development and deployment of an integrated mHealth platform that is able to capture medical information, including test results, and encrypt it into a patient-held smartcard that can be read at the point of delivery without the need for an Internet connection. Methods We engaged a team of implementation scientists, public health experts, and information technology specialists in a requirement-gathering process to inform the design of a prototype for a platform that uses smartcard technology, database deployment, and mobile phone app development. Key design decisions focused on usability, scalability, and security. Results We successfully designed an integrated mHealth platform and deployed it in 4 health facilities across Benue State, Nigeria. We developed the Vitira Health platform to store test results of HIV, HBV, and SCD in a database, and securely encrypt the results on a Quick Response code embedded on a smartcard. We used a mobile app to read the contents on the smartcard without the need for Internet connectivity. Conclusions Our findings indicate that it is possible to develop a patient-held smartcard and an mHealth platform that contains vital health information that can be read at the point of delivery using a mobile phone-based app without an Internet connection. Trial Registration ClinicalTrials.gov NCT03027258; https://clinicaltrials.gov/ct2/show/NCT03027258 (Archived by WebCite at http://www.webcitation.org/6owR2D0kE)

[1]  S. Hay,et al.  Global Burden of Sickle Cell Anaemia in Children under Five, 2010–2050: Modelling Based on Demographics, Excess Mortality, and Interventions , 2013, PLoS medicine.

[2]  J. Iwelunmor,et al.  An mHealth Framework to Improve Birth Outcomes in Benue State, Nigeria: A Study Protocol , 2017, JMIR research protocols.

[3]  G. Ogedegbe,et al.  Comparative effectiveness of congregation- versus clinic-based approach to prevention of mother-to-child HIV transmission: study protocol for a cluster randomized controlled trial , 2013, Implementation Science.

[4]  A. Adanikin,et al.  Role of reminder by text message in enhancing postnatal clinic attendance , 2014, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[5]  Elizabeth Hazel,et al.  Countdown to 2015: a decade of tracking progress for maternal, newborn, and child survival , 2016, The Lancet.

[6]  B. Utoo,et al.  Hepatitis B surface antigenemia (HBsAg) among pregnant women in southern Nigeria. , 2013, African health sciences.

[7]  F. Hsieh,et al.  Efficacy of Hepatitis B Immune Globulin for Prevention of Perinatal Transmission of the Hepatitis B Virus Carrier State: Final Report of a Randomized Double‐Blind, Placebo‐Controlled Trial , 2007, Hepatology.

[8]  A. Ike,et al.  Studies on Prevalence, Co-Infection and Associated Risk Factors of Hepatitis B Virus (HBV) and Human Immunodeficiency Virus (HIV) in Benue State, Nigeria , 2014 .

[9]  Wei Yang,et al.  Prevalence of Sickle Cell Trait and Reliability of Self-Reported Status among Expectant Parents in Nigeria: Implications for Targeted Newborn Screening , 2016, Public Health Genomics.

[10]  A. F. Flening The presentation, management and prevention of crisis in sickle cell disease in Africa , 1989 .

[11]  M. Newell,et al.  Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  L. Mofenson Successes and challenges in the perinatal HIV-1 epidemic in the United States as illustrated by the HIV-1 Serosurvey of childbearing women. , 2004, Archives of pediatrics & adolescent medicine.

[13]  Li Lin,et al.  A model for the adoption of ICT by health workers in Africa , 2012, Int. J. Medical Informatics.

[14]  R. Ugwu,et al.  Nonvertical (horizontal) route of HIV transmission in children. , 2014, Journal of acquired immune deficiency syndromes.

[15]  Utoo Bt Hepatitis B surface antigenemia (HBsAg) among pregnant women in southern Nigeria. , 2014 .

[16]  J. Pharr,et al.  Effect of a congregation-based intervention on uptake of HIV testing and linkage to care in pregnant women in Nigeria (Baby Shower): a cluster randomised trial. , 2015, The Lancet. Global health.

[17]  S. Krugman,et al.  Perinatal hepatitis B virus transmission in the United States. Prevention by passive-active immunization. , 1985 .

[18]  A. Fleming The presentation, management and prevention of crisis in sickle cell disease in Africa. , 1989, Blood reviews.

[19]  Emeka Chukwu,et al.  Assessment of the Quality of Antenatal Care Services Provided by Health Workers Using a Mobile Phone Decision Support Application in Northern Nigeria: A Pre/Post-Intervention Study , 2015, PloS one.

[20]  L. Mofenson,et al.  Advances and research directions in the prevention of mother-to-child HIV-1 transmission , 2000, The Lancet.